XML 102 R76.htm IDEA: XBRL DOCUMENT v3.25.0.1
EQUITY - Schedule of Stock Options, SARS, and Non-vested Restricted Stock (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Non-vested Restricted Stock      
Outstanding, beginning of year (in shares) 114,353 100,025 103,891
Granted (in shares) 39,333 59,745 38,668
Canceled (in shares) (4,854) (62) (2,711)
Vested and issued (in shares) (51,893) (45,355) (39,823)
Outstanding, end of year (in shares) 96,939 114,353 100,025
Weighted- Average Grant Date Fair Value      
Outstanding, beginning of year (in dollars per share) $ 120.13 $ 91.84 $ 78.55
Granted (in dollars per share) 197.52 135.56 120.14
Canceled (in dollars per share) 160.27 88.68 97.44
Vested and issued (in dollars per share) 107.33 78.12 84.25
Outstanding, end of year (in dollars per share) $ 156.37 $ 120.13 $ 91.84
SARs      
Stock Options and SARs      
Outstanding, beginning of year (in shares) 125,952 132,163 130,409
Granted (in shares) 15,465 16,761 18,432
Exercised (in shares) (34,728) (22,972) (16,678)
Canceled (in shares) 0 0 0
Outstanding, end of year (in shares) 106,689 125,952 132,163
Exercisable at end of year (in shares) 73,906 87,378 83,054
Weighted- Average Exercise Price      
Outstanding, beginning of year (in dollars per share) $ 87.18 $ 75.82 $ 66.10
Granted (in dollars per share) 198.54 135.12 120.38
Exercised (in dollars per share) 65.59 56.82 49.04
Canceled (in dollars per share) 0 0 0
Outstanding, end of year (in dollars per share) 110.35 87.18 75.82
Exercisable at end of year (in dollars per share) $ 87.31 $ 73.15 $ 63.12